Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ADMA
NRIX
Add up to 3 more stocks
ADMA
ADMA Biologics, Inc.
+0.69%
$10.18+0.07Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.36B
52W Range
$7.21 - $25.67
NRIX
Nurix Therapeutics, Inc.
-1.22%
$22.60-0.28Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.35B
52W Range
$9.00 - $28.23
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.54 | N/A |
| Forward P/E | 12.78 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.78 | 5.83 |
| P/S Ratio | 4.61 | 63.79 |
| P/FCF Ratio | 20.26 | N/A |
| EV/EBITDA | 10.74 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 64.7% | 77.5% |
| Operating Margin | 42.3% | -340.2% |
| Net Margin | 33.0% | -928.4% |
| ROE | 41.4% | -84.8% |
| ROA | 24.7% | -63.7% |
| ROIC | 27.6% | -77.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.97 | 6.34 |
| Quick Ratio | 3.81 | 6.34 |
| Debt/Equity | 0.50 | 0.14 |
| Interest Coverage | 26.93 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.